DONNA ELLAMIL-LEJARDE: Open Payments
NPI 1558021832 · CATHEDRAL CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 13 payments from 7 companies in 2025. Trend: 2023 $872 · 2024 $832 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $180 |
| AstraZeneca Pharmaceuticals LP | 2 | $142 |
| Indivior Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $28 |
| ABBVIE INC. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Ardelyx, Inc. | 1 | $16 |
Products named: Wegovy, FARXIGA, SUBLOCADE, MOUNJARO, UBRELVY, Ozempic, XIFAXAN, IBSRELA.
Industry payments across CA — which companies pay providers there.
